Biologics subject matter expert (SME) consulting services
Ended Purchase Order Awarded Last action
- Contract number
- 75N95022P00212
- Awardee
-
Voisin Consulting, Inc. UEI KE51NB7CLKE3
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $684,850
Award facts
- Opportunity
-
- Biological Therapeutics Product Development Subject Matter Expert Consulting Services to Support the Development of Therapeutic Biotechnology Products (Biologics) Solicitation · NIHNINDSCSS22000015 · Posted Oct 29, 2021
- Contract value 14% obligated
-
- $684,849.62 Current, with exercised options
- $4,947,189.56 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- Total Small Business
- Competition
- Competed under SAP · 6 offers Simplified Acquisition
- Pricing
- Labor Hours
- Place of performance
- Cambridge, MA 02142, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $88,838 | |
| Exercise an Option | $86,063 | |
| Funding Only Action | -$46,939 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $123,600 | |
| Exercise an Option | $7,500 | |
| Exercise an Option | $112,500 | |
| Exercise an Option | $7,500 | |
| Supplemental Agreement for work within scope | -$598 | |
| Supplemental Agreement for work within scope | -$14,068 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $172,500 | |
| Exercise an Option | $36,431 | |
| Exercise an Option | $14,768 | |
| Supplemental Agreement for work within scope | $10,185 | |
| Exercise an Option | $17,823 | |
| Exercise an Option | $17,823 | |
| Exercise an Option | $20,370 | |
| Exercise an Option | $10,185 | |
| Original award | $20,370 |
Show all 20
About this award
The National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency of the U.S. government, awarded a $4,947,189.56 purchase order contract to Voisin Consulting, Inc. for biological therapeutics subject matter expert (SME) consulting services. The contract is a total small business set-aside with a performance period from April 2022 through April 2025. The SMEs will provide technical recommendations and advice to support the translational development of novel biologics for NINDS initiatives such as the Blueprint Neurotherapeutics Network Biologics (BPN-Biologics) program, the NINDS Ultra-Rare Gene Therapy (URGenT) program, and the Helping to End Addiction Long-term Pain Therapeutics Development Program (HEAL-PTDP). The consultants will advise on candidate biologics therapeutics development, current Good Manufacturing Practices (cGMP) manufacturing, and Phase 1 clinical trials evaluations.
Quick answers
Who was awarded contract 75N95022P00212?
75N95022P00212 was awarded to Voisin Consulting, Inc. by National Institute on Drug Abuse (National Institutes of Health) on April 15, 2022.
How much is contract 75N95022P00212 worth?
The government has obligated $684,850 on 75N95022P00212. Its potential value, with all options, is $4,947,190.
Which agency awarded contract 75N95022P00212?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95022P00212, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Was contract 75N95022P00212 competed?
The extent of competition for 75N95022P00212 was competed under sap. The government received 6 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award